SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
PSDV - pSivida Limited
An SI Board Since November 2005
Posts SubjectMarks Bans Symbol
421 8 0 PSDV
Emcee:  John McCarthy Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
296Alimera Sciences to Present at Two Investor Conferences in September Press ReleJohn McCarthy-9/8/2010
295FDA grants priority review to Alimera drug Iluvien FDA grants priority review tJohn McCarthy-8/30/2010
294THE SPARK: <B>On Aug. 30, the FDA is expected to make a decision on whetJohn McCarthy-8/27/2010
293pSivida Announces Submission of Marketing Authorization Application for an OphthJohn McCarthy-7/8/2010
292Alimera Sciences Submits Iluvien(R) NDA to the FDA for the Treatment of DiabeticJohn McCarthy-6/29/2010
291InNexus Announces Discovery of Novel Protein for AMD Eye Disorder - Will BypasJohn McCarthy-6/29/2010
290pSivida Announces Submission of NDA to FDA for an Ophthalmic Product for DiabetiJohn McCarthy-6/29/2010
289Top 5 Companies in the Life Sciences Tools & Services Industry With the HiJohn McCarthy-6/15/2010
288pSivida CEO to Speak at Glaucoma & Retinopathies 2010 Conference in London John McCarthy-6/15/2010
287Oppenheimer Initiates Coverage on Alimera Sciences (ALIM) with an Outperform MoJohn McCarthy-6/6/2010
286UPDATE - Citi Initiates Coverage on Alimera Sciences (ALIM) with a Buy; BringingJohn McCarthy-6/3/2010
285Hi Arthur IF ... (A) Spain would just collapse -and- (B) ALIM file LATJohn McCarthy-5/28/2010
284Saw the PR.......looks good!Arthur Radley-5/27/2010
283Alimera Announces Iluvien(R) Post 24-Month Visual Acuity Data Indicates SignificJohn McCarthy-5/27/2010
282Charging schemes: Price hangs on patient outcomes By Andrew Jack Published: MaJohn McCarthy-5/5/2010
281NHS investigating cheaper eye medication National Institute of Health and ClinicJohn McCarthy-5/5/2010
280PSDV Conf Call - May 12th WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida Corp. (NASJohn McCarthy-5/5/2010
279ARVO Home Page arvo.org Search abstractsonline.com =========================John McCarthy-4/30/2010
278Results of Studies Using pSivida Technologies in Glaucoma and Degenerative Eye DJohn McCarthy-4/29/2010
277pSivida Receives $15 million payment from Alimera Sciences WATERTOWN, Mass.--(BJohn McCarthy-4/28/2010
276Hi Arthur I think they came up short on their target ($87 million) by apprx $1John McCarthy-4/22/2010
275John, Disappointing that they came with IPO at $11.00 and stock has had no bouncArthur Radley-4/22/2010
274Alimera Sciences Linked In Current Employees (29 total) linkedin.comJohn McCarthy-4/21/2010
273Alimera Sciences, which is developing an injectable implant to treat eye diseaseJohn McCarthy-4/21/2010
272PSDV - my forward Cash Assumptions - Now thru August .... If we ASSUME 8 milJohn McCarthy-4/18/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News